PCA
CLOV icon

Providence Capital Advisors’s Clover Health Investments CLOV Stock Holding History

Providence Capital Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-250
Closed -$270 – 341
2023
Q3 		$270 Hold
250
– – ﹤0.01% 342
2023
Q2 		$224 Hold
250
– – ﹤0.01% 305
2023
Q1 		$211 Buy
+250
New +$274 ﹤0.01% 303

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Providence Capital Advisors's CLOV Position: Q4 2023 in Review

Providence Capital Advisors sold out of Clover Health Investments (CLOV) in Q4 2023, closing a stake of 250 shares — an estimated $270 sold.

Providence Capital Advisors first reported a position in CLOV in Q1 2023 and held it in 3 quarters. The position peaked at $270 in Q3 2023. 144 funds tracked by Wall St. Rank hold CLOV as of Q4 2023.

  • Providence Capital Advisors reported no remaining Clover Health Investments position as of Q4 2023 after selling out during the quarter.
  • Providence Capital Advisors sold 250 Clover Health Investments shares in Q4 2023, an estimated $270.
  • Providence Capital Advisors first reported a position in Clover Health Investments in Q1 2023 and held it in 3 quarters.
  • Providence Capital Advisors's Clover Health Investments position peaked at $270 in Q3 2023.
  • 144 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2023.

Based on Providence Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.